Drug intelligence / Profile preview

Nitrosoethane

Development stage: Unknown
Modality: Small Molecules

Overview

Nitrosoethane (EtNO) is a small organic nitroso compound. It has been identified as a product formed during the photolysis of solid nitromethane. Nitrosoethane is known for its ability to interact with heme proteins, such as ferrous horse heart myoglobin, forming stable adducts. Structural studies have revealed that the nitroso oxygen atom of the EtNO ligand forms a hydrogen bond with the imidazole N(epsilon) atom of the distal His64 residue within the myoglobin structure.

Other names: EtNO

Beyond the preview

Go deeper on Nitrosoethane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nitrosoethane.

Explore the full profile